STAAR Surgical reported $167.13M in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
Abbott USD 6.95B 419M Jun/2025
Bausch Health Companies USD 1.73B 593M Jun/2025
Boston Scientific USD 725M 311M Mar/2025
Cooper Companies USD 124.9M 8.7M Jul/2025
Exact Sciences USD 657.1M 650.98M Jun/2025
Hologic USD 1.74B 305.7M Jun/2025
J&J USD 38.47B 32.35B Mar/2025
Merit Medical Systems USD 341.82M 53.71M Jun/2025
Novartis USD 6.66B 410M Jun/2025
STAAR Surgical USD 167.13M 5.98M Jun/2025